SOPH
Price:
$5.02
Market Cap:
$336.95M
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Industry
Medical - Healthcare Information Services
IPO Date
2021-07-23
Stock Exchange
NASDAQ
Ticker
SOPH
According to SOPHiA GENETICS S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -4.48. This represents a change of 47.13% compared to the average of -3.04 of the last 4 quarters.
The mean historical PE Ratio of SOPHiA GENETICS S.A. over the last ten years is -10.42. The current -4.48 PE Ratio has changed 4.20% with respect to the historical average. Over the past ten years (40 quarters), SOPH's PE Ratio was at its highest in in the September 2022 quarter at -1.81. The PE Ratio was at its lowest in in the June 2020 quarter at -25.61.
Average
-10.42
Median
-3.86
Minimum
-31.67
Maximum
0
Discovering the peaks and valleys of SOPHiA GENETICS S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 155.73%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -31.67
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.25 | -15.95% |
| 2023 | -3.86 | 155.73% |
| 2022 | -1.51 | -87.64% |
| 2021 | -12.22 | -40.11% |
| 2020 | -20.40 | -35.58% |
| 2019 | -31.67 | -Infinity% |
The current PE Ratio of SOPHiA GENETICS S.A. (SOPH) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.87
5-year avg
-8.25
10-year avg
-10.42
SOPHiA GENETICS S.A.’s PE Ratio is greater than Simulations Plus, Inc. (-6.52), less than Definitive Healthcare Corp. (-1.41), less than Kindly MD, Inc. (-1.24), greater than Alto Neuroscience, Inc. (-5.58), greater than Cellectis S.A. (-8.28), less than National Research Corporation (22.53), less than OptimizeRx Corporation (7.98K), less than Agilon Health, Inc. (-0.98), greater than AC Immune S.A. (-4.61), less than Larimar Therapeutics, Inc. (-2.36),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.52 | $412.76M | |
| -1.41 | $264.46M | |
| -1.24 | $207.24M | |
| -5.58 | $415.67M | |
| -8.28 | $484.47M | |
| 22.53 | $371.73M | |
| 7.98K | $270.94M | |
| -0.98 | $301.74M | |
| -4.61 | $289.73M | |
| -2.36 | $314.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SOPHiA GENETICS S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SOPHiA GENETICS S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SOPHiA GENETICS S.A.'s PE Ratio?
How is the PE Ratio calculated for SOPHiA GENETICS S.A. (SOPH)?
What is the highest PE Ratio for SOPHiA GENETICS S.A. (SOPH)?
What is the 3-year average PE Ratio for SOPHiA GENETICS S.A. (SOPH)?
What is the 5-year average PE Ratio for SOPHiA GENETICS S.A. (SOPH)?
How does the current PE Ratio for SOPHiA GENETICS S.A. (SOPH) compare to its historical average?